- Home
- CCNE vs RNAC Comparison
CCNE vs RNAC Comparison
Compare CCNE & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCNE
- RNAC
- Stock Information
- Founded
- CCNE 1865
- RNAC 2007
- Country
- CCNE United States
- RNAC United States
- Employees
- CCNE N/A
- RNAC N/A
- Industry
- CCNE Major Banks
- RNAC Biotechnology: Pharmaceutical Preparations
- Sector
- CCNE Finance
- RNAC Health Care
- Exchange
- CCNE Nasdaq
- RNAC Nasdaq
- Market Cap
- CCNE 485.2M
- RNAC 472.7M
- IPO Year
- CCNE N/A
- RNAC 2016
- Fundamental
- Price
- CCNE $27.63
- RNAC $17.33
- Analyst Decision
- CCNE Hold
- RNAC Strong Buy
- Analyst Count
- CCNE 1
- RNAC 7
- Target Price
- CCNE $22.00
- RNAC $40.80
- AVG Volume (30 Days)
- CCNE 60.0K
- RNAC 107.5K
- Earning Date
- CCNE 10-21-2024
- RNAC 11-07-2024
- Dividend Yield
- CCNE 2.61%
- RNAC N/A
- EPS Growth
- CCNE N/A
- RNAC N/A
- EPS
- CCNE 2.33
- RNAC N/A
- Revenue
- CCNE $216,515,000.00
- RNAC $47,938,000.00
- Revenue This Year
- CCNE N/A
- RNAC $69.22
- Revenue Next Year
- CCNE $8.80
- RNAC N/A
- P/E Ratio
- CCNE $11.86
- RNAC N/A
- Revenue Growth
- CCNE N/A
- RNAC N/A
- 52 Week Low
- CCNE $17.74
- RNAC $11.67
- 52 Week High
- CCNE $29.29
- RNAC $42.60
- Technical
- Relative Strength Index (RSI)
- CCNE 59.25
- RNAC 39.04
- Support Level
- CCNE $26.76
- RNAC $15.50
- Resistance Level
- CCNE $29.03
- RNAC $22.20
- Average True Range (ATR)
- CCNE 0.93
- RNAC 1.65
- MACD
- CCNE 0.09
- RNAC -0.56
- Stochastic Oscillator
- CCNE 65.63
- RNAC 24.43
About CCNE CNB Financial Corporation
CNB Financial Corp is providing integrated financial solutions, which create value for both consumers and businesses. These solutions encompass deposit accounts, private banking, real estate, commercial, industrial, residential and consumer loans and lines of credit, credit cards, treasury services, online banking, mobile banking, merchant credit card processing, remote deposit and accounts receivable handling. In addition, the corporation provides wealth and asset management services, retirement plans and other employee benefit plans.
About RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. It leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.